These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34380021)

  • 1. Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing.
    Chen J; Li W
    Stem Cell Reports; 2021 Aug; 16(8):1868-1873. PubMed ID: 34380021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From strict moral standards to ethical neutrality: a policy-guided shift in the patentability of human embryonic stem cells in China.
    Xie X; Chen J; Shu Z
    Stem Cell Res Ther; 2020 Nov; 11(1):499. PubMed ID: 33239089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent eligibility of stem cells in Europe: where do we stand after 8 years of case law?
    Storz U; Faltus T
    Regen Med; 2017 Jan; 12(1):37-51. PubMed ID: 27976982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling promotes self-renewal and inhibits the primed state transition in naïve human embryonic stem cells.
    Xu Z; Robitaille AM; Berndt JD; Davidson KC; Fischer KA; Mathieu J; Potter JC; Ruohola-Baker H; Moon RT
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6382-E6390. PubMed ID: 27698112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting stem cell technologies in Europe.
    Sheard A
    Cold Spring Harb Perspect Med; 2014 Nov; 5(3):a021089. PubMed ID: 25395376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Patentability of Stem Cells in Australia.
    Petering J; Cowin P
    Cold Spring Harb Perspect Med; 2015 Jul; 5(10):. PubMed ID: 26134481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brüstle v. Greenpeace: Implications for Commercialisation of Translational Stem Cell Research.
    Mansnérus J
    Eur J Health Law; 2015 Apr; 22(2):141-64. PubMed ID: 26399054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal and regulatory news from Europe.
    Hitchcock J
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():44-6. PubMed ID: 25457961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.
    Couture LA; Carpenter MK
    Stem Cells Transl Med; 2015 Oct; 4(10):1097-100. PubMed ID: 26285658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European stem cell research in legal shackles.
    Nielen MG; de Vries SA; Geijsen N
    EMBO J; 2013 Dec; 32(24):3107-11. PubMed ID: 24270573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tfcp2l1 safeguards the maintenance of human embryonic stem cell self-renewal.
    Sun H; You Y; Guo M; Wang X; Zhang Y; Ye S
    J Cell Physiol; 2018 Sep; 233(9):6944-6951. PubMed ID: 29323720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of Human Embryonic Stem Cells and Their Differentiated Derivatives Depend on Nonhistone DNA-Binding HMGB1 and HMGB2 Proteins.
    Bagherpoor AJ; Dolezalova D; Barta T; Kučírek M; Sani SA; Ešner M; Kunova Bosakova M; Vinarský V; Peskova L; Hampl A; Štros M
    Stem Cells Dev; 2017 Mar; 26(5):328-340. PubMed ID: 27863459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in human embryonic stem cell research in the United States between 2001 and 2010.
    Vakili K; McGahan AM; Rezaie R; Mitchell W; Daar AS
    PLoS One; 2015; 10(3):e0120052. PubMed ID: 25812114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revealing the metabolic characteristics of human embryonic stem cells by genome-scale metabolic modeling.
    He Y; Wang Y; Zhang B; Li Y; Diao L; Lu L; Yao J; Liu Z; Li D; He F
    FEBS Lett; 2018 Nov; 592(22):3670-3682. PubMed ID: 30223296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Europe rules against stem-cell patents.
    Abbott A
    Nature; 2011 Mar; 471(7338):280. PubMed ID: 21412307
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for stem cell patent applications in the light of recent court cases.
    Eyre DE; Schlich GW
    Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin coordinates with Jup and the TCF1/GATA6 axis to regulate human embryonic stem cell fate.
    Sun H; Wang X; Liu K; Guo M; Zhang Y; Ying QL; Ye S
    Dev Biol; 2017 Nov; 431(2):272-281. PubMed ID: 28943339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
    Mansnérus J
    Eur J Health Law; 2015 Jun; 22(3):267-86. PubMed ID: 26399046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature journals formalize ethical standards for human embryo and stem-cell research.
    Nature; 2018 May; 557(7703):6. PubMed ID: 29720640
    [No Abstract]   [Full Text] [Related]  

  • 20. Stem cells: research tools and clinical treatments.
    Fahey MC; Wallace EM
    J Paediatr Child Health; 2011 Sep; 47(9):672-5. PubMed ID: 21951457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.